跳至主要内容
临床试验/JPRN-jRCT1092220091
JPRN-jRCT1092220091已完成Unknown

Clinical trial to evaluate the efficacy and safety of nDM-14R intended for two-stage operation cases.

Kawasumi. laboratory .inc0 个研究点目标入组 130 人开始时间: 2012年7月2日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • (1) Patients of 20 years or more at the time of obtaining informed consent.
  • (2) Patient who will have covering colostomy and colostomy closure.
  • (3) Patient or legal representative who well understand the protocol with written informed consent.

排除标准

  • (1) Patient scheduled for first-stage laparoscopic surgery.
  • (2) Patient who need intraperitoneal injection of perfusate of drugs that affect on adhesion formation during 24 hours to 7 days after first-stage surgery.
  • (3) Patient who have had previous abdominal median incision.
  • (4) Cancer patient of stageIV.
  • (5) Patient with ECOG Performance Status over 3.
  • (6) Patient with a history of severe drug allergy.
  • (7) Patient with an allergy to materials of investigational device.
  • (8) Patient with body-wide infection.
  • (9) Patient who wish to become pregnant during the study or pregnant, lactating.
  • (10) Patient from the course of the disease, life expectancy less than one year.
  • (11) Participation in other clinical studies either concurrently or within the last three months.
  • (12) Patient who were deemed inappropriate as the subject of clinical trial.

研究者

发起方
Kawasumi. laboratory .inc

相似试验